Hospital procurement of orthopedic implants is governed by a complex interaction between group purchasing organization contracts, hospital value analysis committee review processes, surgeon preference, and the economics of bundled payment reimbursement. GPO contracts — administered by Premier, Vizient, HealthTrust, and other national GPOs — influence the majority of hospital orthopedic purchasing decisions through tiered pricing structures that reward volume commitment and sole-source contracting.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• GPO Structure and Contracting Dynamics
• Value Analysis Committee Process
• Surgeon Preference Item Strategy
• Bundled Payment Impact on Implant Selection
• Total Cost of Care Analysis
• OEM Contracting Strategy
Table of Contents
1. Executive Summary
2. Landscape Overview
3. GPO Structure and Contracting Dynamics
4. Value Analysis Committee Process
5. Surgeon Preference Item Strategy
6. Bundled Payment Impact on Implant Selection
7. Total Cost of Care Analysis
8. OEM Contracting Strategy
9. Competitive Landscape
10. Strategic Conclusions and Recommendations
11. Appendix
List of Tables
Table 1. Overview and Key Data 2025
Table 2-8. Topic-Specific Analysis Tables
Table 2. Leading Suppliers — Strategy Assessment 2025
Table 3. Key Risks and Mitigation Strategies
Companies Profiled
Aesculap
Arthrex
DePuy Synthes
Enovis
Globus Medical
NuVasive
Smith & Nephew
Stryker
Wright Medical
Zimmer Biomet
